Federica Sella
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.
Journal: Journal of cutaneous pathology
Published: December 15, 2025
In vivo single-cell ribosome profiling reveals cell-type-specific translational programs during aging.
Journal: Molecular cell
Published: November 26, 2025
Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Journal: EMBO molecular medicine
Published: August 20, 2024
Inflammatory Cutaneous Reactions with Systemic CD8+ T-Cell Responses upon Photochemical Internalization of Antigens in Mice.
Journal: The Journal of investigative dermatology
Published: August 09, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma.
Journal: Nature cancer
Published: December 01, 2023
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
Journal: The British journal of dermatology
Published: October 02, 2023
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Journal: EMBO molecular medicine
Published: March 17, 2023
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma.
Journal: Cancer research
Published: February 14, 2023
Last Updated: 09/26/2026